Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Watts

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 26, 2024
Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous systemMichael P Moazami, Julia M Rembetsy-Brown, Samantha L Sarli, et al.
Nature Medicine|December 24, 2021
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotideHélène Tran, Michael P Moazami, Huiya Yang, et al.
Elife|October 19, 2021
5'-Modifications improve potency and efficacy of DNA donors for precision genome editingKrishna S Ghanta, Zexiang Chen, Aamir Mir, et al.
Nucleic Acids Research|August 3, 2022
Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblastsMinwook Shin, Io Long Chan, Yuming Cao, et al.
Nature Biotechnology|September 25, 2024
Increasing intracellular dNTP levels improves prime editing efficiencyPengpeng Liu, Karthikeyan Ponnienselvan, Thomas Nyalile, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Fully Modified SpyCas9 Guide RNAs Enable Robust Genome Editing In Cells and In VivoKim Anh Vu, Han Zhang, Nadia Amrani, et al.
European Urology Oncology|January 23, 2024
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant ChemotherapySean A Fletcher, Maximilian Pallauf, Emelia K Watts, et al.
Lancet (London, England)|May 25, 2025
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case seriesNeil A Shneider, Matthew B Harms, Vlad A Korobeynikov, et al.
Nature Neuroscience|November 1, 2025
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTDBrian J Joseph, Kelly A Marshall, Peter Harley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infectionVignesh N Hariharan, Minwook Shin, Ching-Wen Chang, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 26, 2024
Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous systemMichael P Moazami, Julia M Rembetsy-Brown, Samantha L Sarli, et al.
Nature Medicine|December 24, 2021
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotideHélène Tran, Michael P Moazami, Huiya Yang, et al.
Elife|October 19, 2021
5'-Modifications improve potency and efficacy of DNA donors for precision genome editingKrishna S Ghanta, Zexiang Chen, Aamir Mir, et al.
Nucleic Acids Research|August 3, 2022
Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblastsMinwook Shin, Io Long Chan, Yuming Cao, et al.
Nature Biotechnology|September 25, 2024
Increasing intracellular dNTP levels improves prime editing efficiencyPengpeng Liu, Karthikeyan Ponnienselvan, Thomas Nyalile, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Fully Modified SpyCas9 Guide RNAs Enable Robust Genome Editing In Cells and In VivoKim Anh Vu, Han Zhang, Nadia Amrani, et al.
European Urology Oncology|January 23, 2024
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant ChemotherapySean A Fletcher, Maximilian Pallauf, Emelia K Watts, et al.
Lancet (London, England)|May 25, 2025
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case seriesNeil A Shneider, Matthew B Harms, Vlad A Korobeynikov, et al.
Nature Neuroscience|November 1, 2025
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTDBrian J Joseph, Kelly A Marshall, Peter Harley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infectionVignesh N Hariharan, Minwook Shin, Ching-Wen Chang, et al.
Pageof 19